Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

600739.SS

HOLDGet insider-trade alerts

Liaoning Cheng Da Co., Ltd. · Healthcare · China · $2.2B · Avg Vol: $20M/d

56
StockRank
Q
37
V
52
M
59
P/E (TTM)
16.4x
ROE
1.5%
D/E
0.5x
Dividend %
1.4%
Director Trades · 180d
None in 180d →
Buybacks · 180d
None in 180d →

COMPANY DESCRIPTION

Liaoning Cheng Da Co., Ltd. is a diversified conglomerate with core businesses in biopharmaceuticals, financial services, and international trade. Through its subsidiary Chengda Biotech, the company holds a dominant global market position in human rabies vaccines, providing a highly profitable and defensive revenue stream. This biopharma moat is complemented by valuable financial assets, including a major equity stake in GF Securities, and a stable commodity trading division.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGRTTM
Revenue2.1B1.5B1.6B1.5B-11.1%1.4B
EPS0.120.020.020.07-15.7%0.09
Shares1.5B1.5B1.5B1.5B0.0%1.5B
Debt1.7B1.9B1.8B1.9B3.5%2.3B
Equity4.2B4.2B4.3B4.2B0.1%—
Op CF210.2M17.6M89.9M49.7M-38.2%64.8M
Inv CF488.2M-142.9M42.6M75.6M——
Fin CF-240.6M-267.2M-119.7M46.6M——
Loading 1Y...
PRICE (1Y)-6.0%
1.471.511.551.591.64May 25Jun 15Jul 6
SMA 50SMA 200
Close
$1.54
RSI (14)
50.2
52W High
$2.00
From 52W High
0.8%

SCORE BREAKDOWN

Quality
37
ROIC
2.5%49.4
ROE
1.5%47.4
GP/Assets
1.4%13.1
Op. Margin
-2.1%33.6
FCF/Assets
1.0%48.9
Piotroski
549.0
Int. Cover
1.6x41.0
D/E Ratio
0.48x32.9
Current Ratio
1.40x23.1
Value
52
P/E (TTM)
16.4x66.9
EV/EBITDA
-64.9x25.0
P/FCF
32.6x37.5
P/B
0.5x94.8
P/S
1.6x72.2
Div Yield
1.4%35.2
Momentum
59
52W High %
77%60.5
RS 6M
-14%54.2
SMA 50/200
0.93x46.6
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
59%78.6

FUNDAMENTALS

Market Cap
$2.2B
P/E (Forward)
—
Gross Margin
7.2%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 600739.SS are excluded.

TickerCompanyMkt CapStockRankSignal
600739.SSLiaoning Cheng Da Co., Ltd.(you)$2.2B56HOLD
000950.SZC.Q. Pharmaceutical Holding Co., Ltd.$1.3B51HOLD
600056.SSChina Meheco Group Co., Ltd.$1.9B80BUY
600998.SSJointown Pharmaceutical Group Co., Ltd$3.4B80BUY
600332.SSGuangzhou Baiyunshan Pharmaceutical Holdings Company Limited$4.7B75BUY
301584.SZShanghai C&D INNOSTIC Medical Technology Group Co., Ltd.$1.2B29SELL
301015.SZQingdao Baheal Medical INC.$1.5B86STRONG BUY
002589.SZRealcan Pharmaceutical Group Co., Ltd.$543M39HOLD
000028.SZChina National Accord Medicines Corporation Ltd.$1.7B96STRONG BUY
600511.SSChina National Medicines Corporation Ltd.$2.9B98STRONG BUY

Peer medians: ROE 4.8% · P/E 26.5x · Gross margin 52.5%

Liaoning Cheng Da Co., Ltd. (600739.SS) — Stock Score Summary

Liaoning Cheng Da Co., Ltd. (600739.SS) has a MoatMap StockRank of 56/100 based on Quality (37/100), Value (52/100), and Momentum (59/100) factor scores. The current signal is HOLD.

Liaoning Cheng Da Co., Ltd. is a diversified conglomerate with core businesses in biopharmaceuticals, financial services, and international trade. Through its subsidiary Chengda Biotech, the company holds a dominant global market position in human rabies vaccines, providing a highly profitable and defensive revenue stream. This biopharma moat is complemented by valuable financial assets, including a major equity stake in GF Securities, and a stable commodity trading division.

Key Financial Metrics

Price$1.54
Market Cap$2.2B
P/E (TTM)16.44
Price/Book0.52
Return on Equity1.5%
Return on Invested Capital2.5%
Debt/Equity47.66
Gross Margin7.2%
Operating Margin-2.1%
Revenue Growth-19.1%
Dividend Yield1.4%
Free Cash Flow$69M

Liaoning Cheng Da Co., Ltd. operates in the Medical Distribution industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Liaoning Cheng Da Co., Ltd.’s (600739.SS) StockRank?
MoatMap’s StockRank for Liaoning Cheng Da Co., Ltd. (600739.SS) is 56/100, with a Hold signal. It is a composite of Quality (37), Value (52), and Momentum (59) factor ranks across MoatMap’s 20,000+ stock universe.
Does Liaoning Cheng Da Co., Ltd. have an economic moat?
Liaoning Cheng Da Co., Ltd. (600739.SS) has a Quality factor score of 37/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Liaoning Cheng Da Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Liaoning Cheng Da Co., Ltd. (600739.SS) is Hold, based on a StockRank of 56/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Liaoning Cheng Da Co., Ltd. in?
Liaoning Cheng Da Co., Ltd. (600739.SS) operates in the Healthcare sector, specifically the Medical Distribution industry (China).
Browse all ranked stocks600739.SS deep dive reportAI ChampionsHow we score stocksSense-check another stock